Injectpower is a pioneering startup that specializes in the development and production of microbatteries for implantable medical devices. These microbatteries have opened up new possibilities for long-term implantable applications, such as direct electrical stimulation and frequent sampling of critical disease markers.

The company's batteries are being integrated into in vivo devices for continuous intraocular pressure (IOP) measurement, and pressure and flow measurement for intracranial fluid (ICP) within existing shunt valves. This means that Injectpower's products are primarily used in the healthcare sector, specifically in the field of digital health and medical technology.

Injectpower's business model revolves around working closely with its partners to develop and supply transformative energy storage products. The company has already produced over 1 million microbatteries, which are being used in innovative devices that allow physicians to remotely monitor ICP and ICF flow. This remote monitoring capability can help doctors determine whether a shunt is obstructed, which can be crucial in managing patient therapy effectively.

The startup recently closed a funding round and is targeting major manufacturing capacity in Grenoble, indicating a strong growth trajectory. Ariel Cao, the co-founder of Injectpower, brings a wealth of experience in team building, organizational management, business development, and technical expertise to the company.

In summary, Injectpower is a promising startup in the digital health sector, leveraging advanced microbattery technology to enable innovative medical applications and improve patient care.

Keywords: Microbatteries, Implantable Medical Devices, Digital Health, Energy Storage Technology, Intraocular Pressure, Intracranial Fluid, Remote Monitoring, Medical Technology, Healthcare Sector, Startup.